UPLC-MS/MS method for the determination of Lenvatinib in rat plasma and its application to drug-drug interaction studies-Reference-Cited by-同舟云学术

UPLC-MS/MS method for the determination of Lenvatinib in rat plasma and its application to drug-drug interaction studies

Published:2021-11 Issue: Volume:206 Page:114360
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Cui Yanjun,Li Ying,Fan Liju,An Jing,Wang Xiaonan,Fu Ran,Dong Zhanjun^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference34 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer J. Clin.,2021

2. Systemic treatment options in hepatocellular carcinoma;Rimassa;Liver Cancer,2019

3. Precision diagnosis and treatment of liver cancer in China;Fu;Cancer Lett.,2018

4. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update;Kudo;Liver Cancer,2020

5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of three flavonoids on the metabolism of lenvatinib;Frontiers in Pharmacology;2024-08-20

2. Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography‐tandem mass spectrometry;Journal of Separation Science;2024-03

3. Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS;Thoracic Cancer;2023-09-28

4. Advancing Quality and Environmental Responsibility: A Stability-Indicating LC Method Development for Lenvatinib Through QbD and Green Chemistry;Chromatographia;2023-08-14

5. Advancing Quality and Environmental Responsibility: A Stability-Indicating LC Method Development for Lenvatinib through QbD and Green Chemistry;2023-08-01